Roberta Rudà

27PUBLICATIONS
186CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesLiquid biopsiesSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 05, 2026
Prognostic Markers in Meningioma: Effectiveness of FISH-Assessed CDKN2A/B Homozygous Deletion and Limits of Surrogate p16/MTAP Immunohistochemistry in Predicting Disease-Specific Survival.

|Aug 19, 2026
Prognostic impact of phosphatase and tensin homolog status in recurrent IDH-wildtype glioblastoma receiving second-line therapy.

|Jun 16, 2026
Long-Term Outcome of Molecularly Defined Oligodendrogliomas: Comparison of Grade 2 and 3 Tumors.

|Sep 16, 2025
Early seizure freedom with [18F]fluorodopa positron emission tomography response after isocitrate dehydrogenase inhibition with vorasidenib: First case report.

Roberta Rudà, Francesco Bruno, Alessia Pellerino

|Sep 02, 2025
Glutamate to GABA ratio is elevated in patients with IDH-mutant lower-grade gliomas and seizures.

Riccardo Pascuzzo, Roberta Rudà, Peter B Barker

|Aug 30, 2025
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium.

Chetan Bettegowda, Houtan Noushmehr, Alessandra Affinito

Pageof 5

Frequent Collaborators

11 joint publications

Riccardo Soffietti

8 joint publications

Alessia Pellerino

7 joint publications

Luca Bertero

6 joint publications

Francesco Bruno